In March 2010, Carilion Labs and Spectrum Laboratory Network merged to form one of the nation’s top ten laboratory companies offering comprehensive clinical, anatomic pathology and esoteric testing services. The history of our combined companies dates back to more than a decade of experience satisfying clients' service needs. There core business of providing accurate, timely and cost-effective laboratory services to healthcare professionals, physician practices, hospitals and medical groups is a testament to our commitment to customer intimacy and service excellence

Spherix Incorporated was launched in 1967 as a scientific research company. The company now leverages its scientific and technical expertise and experience through its two subsidiaries—Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is currently conducting a Phase 3 clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose already approved as a sugar substitute, as a treatment for glycemic control in patients with Type 2 diabetes. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides.

When the ailing wish upon a star, Wistar might be able to find them a cure. Founded in 1892, The Wistar Institute is a not-for-profit biomedical research institution concentrating on major diseases such as cancer, immune-system disorders, heart ailments, and infectious diseases. The institute operates from about 30 laboratories with research programs targeting genetic, molecular, and cellular discoveries. The company's research has been used in the development of vaccines, pharmaceuticals, and biotechnology drugs. Wistar collaborates with educational and governmental partners.

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. They are currently conducting Phase 3 trials for torezolid phosphate (TR-701), an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections.

US LABS is a leading esoteric oncology and hematopathology laboratory focused on quality, innovation, and client services. Our passion for quality and attention to detail is evident in the time and care our pathology staff takes with each case. Reading more than 250,000 cases a year, our pathologists have a broad range of experience to approach diagnostic challenges. US LABS delivers a personal touch in removing any barrier between client and pathologist, as our doctors are available throughout the day for consultation on difficult cases.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.